SEC 13F Intelligence

Nantahala Capital Management, LLC / SLNOEUR

Nantahala Capital Management, LLC’s Soleno Therapeutics Inc Position

Does Nantahala Capital Management, LLC own Soleno Therapeutics Inc (SLNOEUR)? Yes — 1.74M shares worth $58M (+2.15% of its 13F portfolio) as of Q1 2026, up from 1.31M shares the prior filed quarter.

Position Value
$58M
Q1 2026
Shares
1.74M
% of Portfolio
+2.15%
Quarters Held
26
currently held

Position History SLNOEUR

Reported value by quarter
Q4 ’19: $13MQ4 ’19Q1 ’20: $10MQ2 ’20: $16MQ3 ’20: $19MQ4 ’20: $15MQ4 ’20Q1 ’21: $10MQ2 ’21: $11MQ3 ’21: $9MQ4 ’21: $4MQ4 ’21Q1 ’22: $2MQ2 ’22: $2MQ3 ’22: $1MQ4 ’22: $1MQ4 ’22Q1 ’23: $1MQ2 ’23: $3MQ3 ’23: $12MQ4 ’23: $230MQ4 ’23Q1 ’24: $103MQ2 ’24: $251MQ3 ’24: $165MQ4 ’24: $177MQ4 ’24Q1 ’25: $126MQ2 ’25: $84MQ3 ’25: $58MQ4 ’25: $61MQ4 ’25Q1 ’26: $58Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.74M$58M+2.15%
Q4 20251.31M$61M+2.01%
Q3 2025863.8K$58M+2.03%
Q2 20251.00M$84M+3.29%
Q1 20251.76M$126M+4.99%
Q4 20243.93M$177M+7.58%
Q3 20243.27M$165M+8.35%
Q2 20246.16M$251M+7.37%
Q1 20242.41M$103M+5.89%
Q4 20235.71M$230M+6.88%
Q3 2023392.4K$12M+0.99%
Q2 2023649.8K$3M+0.27%
Q1 2023699.4K$1M+0.11%
Q4 2022604.2K$1M+0.08%
Q3 2022604.2K$1M+0.07%
Q2 20229.44M$2M+0.08%
Q1 20229.44M$2M+0.09%
Q4 20219.77M$4M+0.14%
Q3 20219.77M$9M+0.28%
Q2 20219.77M$11M+0.32%
Q1 20217.82M$10M+0.29%
Q4 20207.87M$15M+0.47%
Q3 20207.43M$19M+0.57%
Q2 20207.43M$16M+0.50%
Q1 20204.28M$10M+0.38%
Q4 20194.28M$13M+0.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nantahala Capital Management, LLC’s full portfolio or all institutional holders of SLNOEUR.